U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}
Group 1 Specified Substance

Class:
G1 SPECIFIED SUBSTANCE

Concept
Status:
US Approved Rx (2014)
Source:
BLA125549
(2014)
Source URL:
First approved in 2014
Source:
BLA125549
Source URL:

Class:
CONCEPT

Concept
Status:
US Approved Rx (2015)
Source:
BLA125546
(2015)
Source URL:
First approved in 2014
Source:
BLA125549
Source URL:

Class:
CONCEPT

Concept
Status:
US Approved Rx (2014)
Source:
BLA125549
(2014)
Source URL:
First approved in 2014
Source:
BLA125549
Source URL:

Class:
CONCEPT

Concept
Status:
US Approved Rx (2014)
Source:
BLA125549
(2014)
Source URL:
First approved in 2014
Source:
BLA125549
Source URL:

Class:
CONCEPT

Concept
Status:
US Approved Rx (2008)
Source:
BLA125145
(2008)
Source URL:

Class:
CONCEPT

Concept
Status:
First approved in 1976
Source:
Asellacrin by Hoechst Roussel
Source URL:

Class:
CONCEPT

Concept
Status:
First approved in 1950

Class:
CONCEPT